This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

Deep circadian phenotyping across breast cancer cell lines reveals distinct circadian subtypes and their impact on drug ...

Despite improvements in neuroblastoma treatment, survival figures lag behind those of many other childhood malignancies. New ...

topotecan, irinotecan, or gemcitabine). The trial was stopped early, following a unanimous recommendation by the Independent Data Monitoring Committee, based on the highly significant effect of ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...